Skip to content
Website Logo
Website Logo
  • Home
  • About Us
  • Leadership
  • Clinical Trials
  • Our Practices
  • Contact Us
News & Events Phase I, open-label, multicentre study of buparlisib in combination with temozolomide or with concomitant radiation therapy and temozolomide in patients with newly diagnosed glioblastoma

Phase I, open-label, multicentre study of buparlisib in combination with temozolomide or with concomitant radiation therapy and temozolomide in patients with newly diagnosed glioblastoma

  • by Quality Cancer Care Alliance
  • July 21, 2020
  • Clinical Updates

https://pubmed.ncbi.nlm.nih.gov/32661186/

  • Home
  • About Us
  • Leadership
  • Clinical Trials
  • Our Practices
  • Contact Us
  • Privacy Policy
  • Statement of Non-Discrimination
  • Sitemap
Copyright 2022 Quality Cancer Care Alliance | Medical Website Design by Practis